Sumitomo to make 200+ staff cuts in Massachusetts amid consolidation
02 May 2023
Acquisition
Roughly a month after announcing plans to merge several units under Sumitomo Pharma America this July, the drugmaker is making cuts in Massachusetts.
Sumitomo Pharma America Holdings and Sumitomo Pharma Oncology have announced a combined 122 layoffs to take effect June 30, according to Massachusetts’
WARN system.
Another Sumitomo unit, Sunovion Pharmaceuticals, will make 101 cuts.
Sumitomo
announced
in early April that it was combining Sunovion, Sumitomo Pharma Oncology, Sumitomo Pharma America Holdings, Sumitovant Biopharma, Myovant Sciences, Urovant Sciences and Enzyvant Therapeutics to form Sumitomo Pharma America. Sumitomo said at the time that the combined company would house a “diverse portfolio of commercialized products and robust pipeline of early- to late-stage assets” across the central nervous system, oncology, urology, women’s health, and cell and gene therapies.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.